These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 39208834

  • 1. Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis.
    Assad Z, Papenburg J, Ouldali N.
    Lancet Child Adolesc Health; 2024 Oct; 8(10):708-709. PubMed ID: 39208834
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.
    Brault A, Pontais I, Enouf V, Debeuret C, Bloch E, Paireau J, Rameix-Welti MA, White M, Baudemont G, Lina B, Parent du Châtelet I, Casalegno JS, Vaux S, Cauchemez S.
    Lancet Child Adolesc Health; 2024 Oct; 8(10):721-729. PubMed ID: 39208833
    [Abstract] [Full Text] [Related]

  • 4. High rate of indigenous bronchiolitis and palivuzumab.
    Whitehall JS, Bolisetty S, Whitehall JP, Francis F, Norton R, Patole SK.
    J Paediatr Child Health; 2001 Aug; 37(4):416-7. PubMed ID: 11547779
    [No Abstract] [Full Text] [Related]

  • 5. Nirsevimab and Hospitalization for RSV Bronchiolitis.
    Assad Z, Romain AS, Aupiais C, Shum M, Schrimpf C, Lorrot M, Corvol H, Prevost B, Ferrandiz C, Giolito A, Valtuille Z, Bendavid M, Cohen JF, Toubiana J, de Pontual L, Delande CF, Levy M, See P, Cohen R, Levy C, Angoulvant F, Lenglart L, Gits-Muselli M, Biran V, Diallo K, Alemede O, El Hebil MM, Durrmeyer X, Labouret G, Casanovas N, Hallak B, Maréchal O, Jung C, Bréhin C, Ouldali N.
    N Engl J Med; 2024 Jul 11; 391(2):144-154. PubMed ID: 38986058
    [Abstract] [Full Text] [Related]

  • 6. Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY).
    Tuffy KM, Ahani B, Domachowske JB, Furuno K, Ji H, Madhi SA, Mankad VS, Hamrén UW, Villafana T, Wang Y, Kelly EJ, Wilkins D.
    Vaccine; 2024 Oct 24; 42(24):126276. PubMed ID: 39241352
    [Abstract] [Full Text] [Related]

  • 7. [Palivizumab and bronchiolitis: need to apply the efficiency in order to join clinical practice to scientific studies].
    González de Dios J, Ochoa Sangrador C.
    Med Clin (Barc); 2005 Apr 02; 124(12):478-9. PubMed ID: 15826590
    [No Abstract] [Full Text] [Related]

  • 8. Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age.
    Cieslak CM.
    Nurs Womens Health; 2024 Feb 02; 28(1):75-79. PubMed ID: 38070539
    [Abstract] [Full Text] [Related]

  • 9. RSVpreF (Abrysvo) and Nirsevimab-alip (Beyfortus) for the Prevention of Respiratory Syncytial Virus Infection.
    Nodelman M, Scott AM.
    Am Fam Physician; 2024 Jun 02; 109(6):578-579. PubMed ID: 38905561
    [No Abstract] [Full Text] [Related]

  • 10. Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments.
    Andina Martínez D, Claret Teruel G, Gijón Mediavilla M, Cámara Otegui A, Baños López L, de Miguel Lavisier B, Ferrero García-Loygorri C, Sánchez Tatay V, Pavlovic Nesic S, Clerigué Arrieta N, Gimeno-Hernández Garza V, Guerra Diez JL, Ranera Málaga A, Escalada Pellitero S, Barrueco Ramos C, Alonso-Cadenas JA, Impact of universal Respiratory Syncytial Virus prophylaxis in Spain Working Group.
    Pediatrics; 2024 Oct 01; 154(4):. PubMed ID: 39257372
    [Abstract] [Full Text] [Related]

  • 11. [Recommendations for palivizumab use. Update 2015].
    Comité de Estudios Fetoneonatales (CEFEN), Fernández Jonusas S, Albas Maubett D, Satragno D, Cattaino A, Martin Alonso M, Rubio C, Nieto R, Comité de Cardiología, Comité de Neumonología, Comité de Infectología, Subcomisión de Epidemiología, Subcomisión de Investigación, Grupo de Trabajo Seguimiento de Alto Riesgo CEFEN, Expertos.
    Arch Argent Pediatr; 2016 Feb 01; 114(1):84-8. PubMed ID: 26914078
    [Abstract] [Full Text] [Related]

  • 12. Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP).
    Francisco L, Cruz-Cañete M, Pérez C, Couceiro JA, Otheo E, Launes C, Rodrigo C, Jiménez AB, Llorente M, Montesdeoca A, Rumbao J, Calvo C, Frago S, Tagarro A.
    An Pediatr (Engl Ed); 2023 Oct 01; 99(4):257-263. PubMed ID: 37743207
    [Abstract] [Full Text] [Related]

  • 13. Nirsevimab to reduce infant morbidity from respiratory syncytial virus.
    Abu-Raya B, Langley JM, Lavoie P.
    CMAJ; 2024 Sep 30; 196(32):E1114-E1117. PubMed ID: 39353638
    [No Abstract] [Full Text] [Related]

  • 14. CDC changes recommendations due to severe nirsevimab shortage during the 2023-2024 RSV season.
    Rahmat ZS, Ahmad S, Malikzai A.
    Pediatr Pulmonol; 2024 Apr 30; 59(4):1108-1109. PubMed ID: 38240360
    [No Abstract] [Full Text] [Related]

  • 15. Respiratory syncytial virus immune globulin: decisions and costs.
    Barton LL, Grant KL, Lemen RJ.
    Pediatr Pulmonol; 2001 Jul 30; 32(1):20-8. PubMed ID: 11416872
    [Abstract] [Full Text] [Related]

  • 16. Management of respiratory syncytial virus infection.
    Kimpen JL.
    Curr Opin Infect Dis; 2001 Jun 30; 14(3):323-8. PubMed ID: 11964851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.
    Wang D, Bayliss S, Meads C.
    Health Technol Assess; 2011 Jan 30; 15(5):iii-iv, 1-124. PubMed ID: 21281564
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of respiratory syncytial virus bronchiolitis].
    Marchac V.
    Arch Pediatr; 2006 Dec 30; 13 Suppl 5():S12-7. PubMed ID: 17550819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.